Adult-onset immunodeficiency - why is it important in rheumatology?

por Peter, Hans-Hartmut
Publicado 2013

32. Emeriti-Treffen in Düsseldorf vom 9. bis 12. September 2021

por Rau, Rolf, Peter, Hans-Hartmut
Publicado 2022

CELL-MEDIATED CYTOTOXICITY DURING REJECTION AND ENHANCEMENT OF ALLOGENEIC SKIN GRAFTS IN RATS

por Peter, Hans-Hartmut, Feldman, Joseph D.
Publicado 1972

Common variable immunodeficiency - an update

por Salzer, Ulrich, Warnatz, Klaus, Peter, Hans Hartmut
Publicado 2012

Analysis of Specific IgG Titers Against Tick-Borne Encephalitis in Patients with Primary Antibody Deficiency Under Immunoglobulin Substitution Therapy: Impact of Plasma Donor Origi...

por Goldacker, Sigune, Witte, Torsten, Huzly, Daniela, Schlesier, Michael, Peter, Hans-Hartmut, Warnatz, Klaus
Publicado 2015

B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide

por Thiel, Jens, Effelsberg, Nora M, Warnatz, Klaus, Schlesier, Michael, Peter, Hans Hartmut, Voll, Reinhard E, Venhoff, Nils
Publicado 2011

Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study

por Maccioni, Livia, Weber, Susanne, Elgizouli, Magdeldin, Stoehlker, Anne-Sophie, Geist, Ilona, Peter, Hans-Hartmut, Vach, Werner, Nieters, Alexandra
Publicado 2018

Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations

por Peter, Hans-Hartmut, Ochs, Hans D., Cunningham-Rundles, Charlotte, Vinh, Donald C., Kiessling, Peter, Greve, Bernhard, Jolles, Stephen
Publicado 2020

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

por Venhoff, Nils, Effelsberg, Nora M., Salzer, Ulrich, Warnatz, Klaus, Peter, Hans Hartmut, Lebrecht, Dirk, Schlesier, Michael, Voll, Reinhard E., Thiel, Jens
Publicado 2012

Human Immunoglobulin M Memory B Cells Controlling Streptococcus pneumoniae Infections Are Generated in the Spleen

por Kruetzmann, Stephanie, Rosado, M. Manuela, Weber, Holger, Germing, Ulrich, Tournilhac, Olivier, Peter, Hans-Hartmut, Berner, Reinhard, Peters, Anke, Boehm, Thomas, Plebani, Alessandro, Quinti, Isabella, Carsetti, Rita
Publicado 2003

Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe

por Kerr, Jacqueline, Quinti, Isabella, Eibl, Martha, Chapel, Helen, Späth, Peter J., Sewell, W. A. Carrock, Salama, Abdulgabar, van Schaik, Ivo N., Kuijpers, Taco W., Peter, Hans-Hartmut
Publicado 2014

Long-Lived Plasma Cells and Memory B Cells Produce Pathogenic Anti-GAD65 Autoantibodies in Stiff Person Syndrome

por Rizzi, Marta, Knoth, Rolf, Hampe, Christiane S., Lorenz, Peter, Gougeon, Marie-Lise, Lemercier, Brigitte, Venhoff, Nils, Ferrera, Francesca, Salzer, Ulrich, Thiesen, Hans-Jürgen, Peter, Hans-Hartmut, Walker, Ulrich A., Eibel, Hermann
Publicado 2010

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

por Nüßlein, Hubert G., Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T., Bensen, William G., Burmester, Gerd R., Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Le Bars, Manuela
Publicado 2015

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

por Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
Publicado 2016

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective...

por Nüßlein, Hubert G, Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Boumpas, Dimitrios, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Rainer, Franz, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Bars, Manuela Le
Publicado 2014

Evaluation of a questionnaire to assess selected infectious diseases and their risk factors: Findings of a multicenter study

por Sievers, Claudia, Akmatov, Manas K., Kreienbrock, Lothar, Hille, Katja, Ahrens, Wolfgang, Günther, Kathrin, Flesch-Janys, Dieter, Obi, Nadia, Michels, Karin B., Fricke, Julia, Greiser, Karin H., Kaaks, Rudolf, Peter, Hans-Hartmut, Pessler, Frank, Nieters, Alexandra, Krause, Gérard
Publicado 2014

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations

por Meyer, Aurore, Guffroy, Aurélien, Blaison, Gilles, Dieudonne, Yannick, Amoura, Zahir, Bonnotte, Bernard, Fiehn, Christoph, Kieffer, Pierre, Lorenz, Hannes Martin, Magy-Bertrand, Nadine, Maurier, François, Pennaforte, Jean-Louis, Peter, Hans-Hartmut, Schwarting, Andreas, Sibilia, Jean, Arnaud, Laurent, Martin, Thierry, Voll, Reinhard Edmund, Korganow, Anne-Sophie
Publicado 2020

High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation

por Rakhmanov, Mirzokhid, Sic, Heiko, Kienzler, Anne-Kathrin, Fischer, Beate, Rizzi, Marta, Seidl, Maximilian, Melkaoui, Kerstina, Unger, Susanne, Moehle, Luisa, Schmit, Nadine E., Deshmukh, Sachin D., Ayata, Cemil Korcan, Schuh, Wolfgang, Zhang, Zhibing, Cosset, François-Loic, Verhoeyen, Els, Peter, Hans-Hartmut, Voll, Reinhard E., Salzer, Ulrich, Eibel, Hermann, Warnatz, Klaus
Publicado 2014